Bioiberica S.A.

BARCELONA, SpainBioiberica S.A. introduced Hyal-Joint, an oral form ofhyaluronic acid formulated for joint health. The ingredient nourishes synovialfluid (a main component found in joints) that is needed for smooth jointmovement. Studies have proven Hyal-Joint can reduce inflammation bysignificantly lowering prostaglandin E2 levels in fibroblast cells culturedunder conditions similar to those of inflammation, according to the company.

For more information, visit www.bioiberica.comor Booth #1025 at SupplySide East.